Mission Critical Group Acquires Point Eight Power
"We're thrilled to welcome Point Eight Power to MCG," stated
By adding Point Eight Power, MCG advances its position as a leader in electrical component and system solutions. With access to a broader range of capabilities and continued investment by MCG, Point Eight Power is poised to accelerate its growth.
"This partnership expands our market access while also continuing our commitment to the local economy," said
Point Eight Power joins a growing roster of other industry-leading experts within MCG, including Mission Critical Facilities International (MCFI), a systems integrator that delivers power solutions, modular data centers, and microgrids, and JTS, a manufacturer of generator/electrical equipment enclosures and modular power systems.
For more information about MCG, please contact [email protected].
About Mission Critical Group
Mission Critical Group (MCG) is a leading provider of power solutions for customers that require power reliability and efficiency. MCG offers comprehensive project design, delivery, startup and ongoing maintenance support services. For more information, please get in touch with [email protected].
MCG Companies:
- Mission Critical Facilities International (MCFI) is a systems integrator that delivers power solutions, modular data centers and microgrids.
- JTS manufactures generator/electrical equipment enclosures and modular power systems.
- Point Eight Power manufactures high-quality, reliable switchgear and power control building solutions.
About Point Eight Power
Located in
View original content to download multimedia:https://www.prnewswire.com/news-releases/mission-critical-group-acquires-point-eight-power-302080236.html
SOURCE Mission Critical Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.I.G. Capital Signs Definitive Agreement to Acquire TERRAS
- Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
- REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share